{"id":26669,"date":"2023-02-10T08:58:27","date_gmt":"2023-02-10T08:58:27","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/pt\/?page_id=26669"},"modified":"2025-11-07T09:44:37","modified_gmt":"2025-11-07T09:44:37","slug":"charles-morris","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris","title":{"rendered":"CHARLES MORRIS"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Charles Morris<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Charles Morris \u00e9 Chief Corporate Development Officer<\/em> e ingressou a Neuraxpharm em janeiro de 2022. Charles \u00e9 um profissional experiente em fus\u00f5es e aquisi\u00e7\u00f5es com 20 anos de experi\u00eancia em banca de investimento e fus\u00f5es e aquisi\u00e7\u00f5es empresariais na ind\u00fastria farmac\u00eautica, em m\u00faltiplas regi\u00f5es geogr\u00e1ficas, incluindo os EUA, Alemanha e Espanha.<\/p>

Antes de ingressar na Neuraxpharm, Charles foi Global Head of M&A and Corporate Development<\/em> na Almirall (2019-2021) e, anteriormente, foi Vice-Presidente, Head of<\/em> Pharma General Medicine & Animal Health <\/em>na\u00a0Bayer AG (2010-2019). No in\u00edcio da sua carreira, Charles trabalhou em banca de investimento e pesquisa de a\u00e7\u00f5es no Bank of America, Merrill Lynch e Molecular Securities em Nova Iorque.<\/p>

Charles tem um MBA da Columbia Business School (EUA) e uma licenciatura em Economia e Ci\u00eancias Pol\u00edticas da Emory University (EUA).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm Charles Morris Charles Morris \u00e9 Chief Corporate Development Officer e ingressou a Neuraxpharm em janeiro de 2022. Charles \u00e9 um profissional experiente em fus\u00f5es e aquisi\u00e7\u00f5es com 20 anos de experi\u00eancia em banca de investimento e fus\u00f5es e aquisi\u00e7\u00f5es empresariais na ind\u00fastria farmac\u00eautica, em m\u00faltiplas regi\u00f5es geogr\u00e1ficas, incluindo os EUA, Alemanha e Espanha. […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-26669","page","type-page","status-publish","hentry"],"yoast_head":"\nCharles Morris - Neuraxpharm PT<\/title>\n<meta name=\"description\" content=\"Descubra o percurso de Charles Morris, Chief Corporate Development Officer na Neuraxpharm. Saiba mais sobre a sua vasta experi\u00eancia em fus\u00f5es e aquisi\u00e7\u00f5es farmac\u00eauticas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CHARLES MORRIS\" \/>\n<meta property=\"og:description\" content=\"Descubra o percurso de Charles Morris, Chief Corporate Development Officer na Neuraxpharm. Saiba mais sobre a sua vasta experi\u00eancia em fus\u00f5es e aquisi\u00e7\u00f5es farmac\u00eauticas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm PT\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-07T09:44:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/pt\/wp-content\/uploads\/sites\/25\/2023\/03\/charles-morris.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/\",\"name\":\"Charles Morris - Neuraxpharm PT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/wp-content\\\/uploads\\\/sites\\\/25\\\/2023\\\/03\\\/charles-morris.jpg\",\"datePublished\":\"2023-02-10T08:58:27+00:00\",\"dateModified\":\"2025-11-07T09:44:37+00:00\",\"description\":\"Descubra o percurso de Charles Morris, Chief Corporate Development Officer na Neuraxpharm. Saiba mais sobre a sua vasta experi\u00eancia em fus\u00f5es e aquisi\u00e7\u00f5es farmac\u00eauticas.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/#primaryimage\",\"url\":\"https:\\\/\\\/static.neuraxpharm.com\\\/wp-content\\\/uploads\\\/sites\\\/25\\\/2023\\\/03\\\/27112956\\\/charles-morris.jpg\",\"contentUrl\":\"https:\\\/\\\/static.neuraxpharm.com\\\/wp-content\\\/uploads\\\/sites\\\/25\\\/2023\\\/03\\\/27112956\\\/charles-morris.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\\\/charles-morris\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Quem somos\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 Executivo\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/quem-somos\\\/comite-executivo\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CHARLES MORRIS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/\",\"name\":\"Neuraxpharm PT\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.neuraxpharm.com\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Charles Morris - Neuraxpharm PT","description":"Descubra o percurso de Charles Morris, Chief Corporate Development Officer na Neuraxpharm. Saiba mais sobre a sua vasta experi\u00eancia em fus\u00f5es e aquisi\u00e7\u00f5es farmac\u00eauticas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris","og_locale":"pt_PT","og_type":"article","og_title":"CHARLES MORRIS","og_description":"Descubra o percurso de Charles Morris, Chief Corporate Development Officer na Neuraxpharm. Saiba mais sobre a sua vasta experi\u00eancia em fus\u00f5es e aquisi\u00e7\u00f5es farmac\u00eauticas.","og_url":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/","og_site_name":"Neuraxpharm PT","article_modified_time":"2025-11-07T09:44:37+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/pt\/wp-content\/uploads\/sites\/25\/2023\/03\/charles-morris.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris","url":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/","name":"Charles Morris - Neuraxpharm PT","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/pt\/wp-content\/uploads\/sites\/25\/2023\/03\/charles-morris.jpg","datePublished":"2023-02-10T08:58:27+00:00","dateModified":"2025-11-07T09:44:37+00:00","description":"Descubra o percurso de Charles Morris, Chief Corporate Development Officer na Neuraxpharm. Saiba mais sobre a sua vasta experi\u00eancia em fus\u00f5es e aquisi\u00e7\u00f5es farmac\u00eauticas.","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/25\/2023\/03\/27112956\/charles-morris.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/25\/2023\/03\/27112956\/charles-morris.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo\/charles-morris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Quem somos","item":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 Executivo","item":"https:\/\/www.neuraxpharm.com\/pt\/quem-somos\/comite-executivo"},{"@type":"ListItem","position":3,"name":"CHARLES MORRIS"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/pt\/#website","url":"https:\/\/www.neuraxpharm.com\/pt\/","name":"Neuraxpharm PT","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/pages\/26669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/comments?post=26669"}],"version-history":[{"count":17,"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/pages\/26669\/revisions"}],"predecessor-version":[{"id":27264,"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/pages\/26669\/revisions\/27264"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/pt\/wp-json\/wp\/v2\/media?parent=26669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}